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A STUDY ON MUCIN HISTOCHEMISTRY AND p63 EXPRESSION IN 
BENIGN AND MALIGNANT PROSTATIC LESIONS. 
ABSTARCT 
INTRODUCTION: 
The diagnosis of limited well differentiated adenocarcinomas of prostate is one 
of most difficult areas of surgical pathology. Benign hyperplasia can sometimes 
mimic adenocarcinomas. 
         Numerous reports have claimed that acidic mucin is absent in benign prostatic 
glands and is present in prostatic adenocarcinomas. 
Prostatic adenocarcinomas are differentiated from benign hyperplasia of 
prostate by absence of basal cell layer. Therefore basal cell marker (p63) is useful in 
differentiating benign hyperplasia of prostate from prostatic adenocarcinoma. 
AIMS AND OBJECTIVES: 
• To study the mucin histochemistry in benign and malignant prostatic lesions. 
• To correlate with P63 expression in benign and malignant prostatic lesions. 
 
MATERIALS AND METHODS:  
Blocks of histopathologically proven benign prostatic hyperplasia and invasive 
prostatic carcinoma are taken up for staining with alcian blue at pH 2.5 to demonstrate 
the mucin character and also with p63 to identify basal cell layer/myoepithelial cells. 
RESULTS: 
In my study, 48% of adenocarcinoma cases showed Alcian blue positivity. 
Positivity was seen both intracellularly and intraluminally in malignant glands. 
Among Adenocarcinomas, well differentiated and intermediate grade showed 100% 
positivity, moderate to poorly differentiated adenocarcinomas showed 56.25%and 
25% of high grade adenocarcinomas. All benign prostatic hyperplasia cases were 
negative for Alcian blue staining. 
CONCLUSION: 
In addition to histomorphology, Alcian blue staining can be used as an 
adjunctive in differentiating benign prostatic hyperplasia from  well differentiated 
prostatic adenocarcinoma. 
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